Professionals 122 results
Capabilities 55 results
Industry
Practice Area
Practice Area
White Collar & Government Investigations
Experience 13 results
Experience
|November 19, 2025
Blockfusion Enters into Business Combination with Blue Acquisition Corp.
Experience
|September 8, 2025
Experience
|June 8, 2025
Insights & News 1,058 results
Non-Fungible Insights: Blockchain Decrypted
|March 13, 2026
|7 Min Read
The close of 2025 highlighted the continuing momentum for the digital asset industry, with regulatory developments accelerating rather than slowing.
Client Alert
|March 9, 2026
|3 Min Read
On January 27, 2026, the U.S. Department of Health and Human Services Office of Inspector General (the OIG) issued a Special Advisory Bulletin (the Bulletin) addressing the application of the federal anti-kickback statute (the AKS) to direct-to-consumer (DTC) prescription drug sales.
The Bulletin, the OIG’s first Special Advisory Bulletin since September 2014, was issued in response to the proliferation of DTC programs. The Bulletin, which sets forth the framework under which a manufacturer’s DTC program presents a low risk of violating the AKS, is viewed by the growing DTC industry as favorable guidance. DTC programs offering modern weight-loss medications, such as GLP-1 drugs, are becoming increasingly popular, and the Bulletin provides a helpful framework to support the viability of these programs.
Press Release
|March 2, 2026
|2 Min Read
Winston & Strawn Adds Former DOJ Litigator Matthew Huppert to Antitrust Practice
Other Results 34 results
Site Content
Site Content
What Is Anti-Bribery and Corruption?
Site Content


